Indonesia vs South Africa: New cases tested for RR-/MDR-TB
Indonesia
94.0%
in 2024
South Africa
95.0%
in 2024
Indonesia rank
76th
South Africa rank
73rd
New cases tested for RR-/MDR-TB over time
- Indonesia
- South Africa
How they compare
South Africa currently reports 95.0% against 94.0% in Indonesia, a difference of 1.0%.
Across all 9 years both countries report, South Africa has been ahead every year.
Indonesia ranks 76th and South Africa ranks 73rd of 192 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.7% | 97.8% | 80.0% | South Africa |
| 2020s | 79.4% | 98.4% | 19.0% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Indonesia or South Africa?
- South Africa, at 95.0% against 94.0% in Indonesia as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Indonesia and South Africa?
- 1.0%, with South Africa ahead.
- How many years of comparable data are there for Indonesia and South Africa?
- 9 years are reported by both, from 2015 to 2024.
- How do Indonesia and South Africa rank globally for new cases tested for rr-/mdr-tb?
- Indonesia ranks 76th and South Africa ranks 73rd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.